Alembic Pharma Shares Rally 4% on Securing Final USFDA Approval
Shares of Alembic Pharmaceuticals Ltd rallied 4% on Monday, 17 November, after the company announced securing final approval from the USFDA for its angina medication....
Tag : USFDA approval
Biocon Shares Gain 3% on Gaining Two USFDA Approvals
Shares of Biocon Ltd were trading in the green and 2% on 18 September after the company’s subsidiary, Biocon Biologics, received approval from the US...
Biocon Shares Trade 1% Higher as Arm Secures USFDA Approval
Shares of Biocon Ltd gained 1% on 28 August after the company announced securing USFDA approval for Sitagliptin Tablets. In its regulatory filing, the company...
JB Chemicals Shares Gain 2% on USFDA Approval
Shares of JB Chemicals and Pharmaceuticals Ltd were trading in the green and 2% higher on 25 June after the business received USFDA approval for...
Lupin Shares Trade Flat on USFDA Approval
Shares of Lupin Ltd were trading flat on 9 May after the company announced securing approval from the United States Food and Drug Administration (USFDA)...
Lupin Shares Trade 1% Higher on Securing USFDA Approval
Shares of Lupin Ltd were trading in the green and 1% higher on 8 May after the company announced securing USFDA approval. In its regulatory...
Gland Pharma Secures USFDA Nod for Latanoprostene Bunod Ophthalmic Solution
Gland Pharma announced on Wednesday, 30 April, that it had received approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug...
Lupin Secures USFDA Approval for Tolvaptan Tablets; Shares Gain
Shares of Lupin Ltd were trading in the green and 2% higher on Thursday, 24 April, after the company announced that USFDA (US Food and...
Caplin Point Subsidiary Secures USFDA Approval
Caplin Point Laboratories Ltd on Wednesday, 23 April, announced that its subsidiary, Caplin Steriles, has secured approval from the United States Food and Drug Administration...
Zydus Lifesciences Secures USFDA Nod for Deflazacort Tablets; Shares Gain
Zydus Lifesciences‘ share price continued its upward momentum for a second straight day, climbing 1% in early trading on 15 April after receiving approval from...